Analysis, modelling and sensing of both physiological and environmental factors for the customized and predictive self-management of Asthma

H2020-PHC-2014-single-stageH2020-PHC-2014-single-stage

RIA - 643607RIA - 643607

WP7 “Dissemination and WP7 “Dissemination and exploitation”exploitation”

Overview and plansOverview and plans

Horizon 2020 Horizon 2020 Communication & Dissemination RequirementsCommunication & Dissemination Requirements

New criteria for Communication & Dissemination:New criteria for Communication & Dissemination:Projects need a Projects need a comprehensive communication plancomprehensive communication plan

To ensure high visibility of the funded actionsTo ensure high visibility of the funded actions To maximise the results of the impactTo maximise the results of the impact

New Open Access Policy:New Open Access Policy: Each beneficiary has to ensure open access to all peer-reviewed Each beneficiary has to ensure open access to all peer-reviewed

scientific publications linked to the project results.scientific publications linked to the project results.

A statement and/or visual means to identify EU fundingA statement and/or visual means to identify EU funding

Without communication, research is not useful,Without communication, research is not useful,

For efforts to have an impact, they need to be knownFor efforts to have an impact, they need to be known

Partners involvedPartners involved

EFA will lead EFA will lead this WP with the support of the following Partner this WP with the support of the following Partner Organisations:Organisations:

Centre for Research and Technology Hellas Centre for Research and Technology Hellas (CERTH)(CERTH) Imperial College London Imperial College London (ICL)(ICL) IHP Microelectronics IHP Microelectronics (IHP)(IHP) University of Patras University of Patras (UPAT)(UPAT) Leiden University Medical Center Leiden University Medical Center (LUMC)(LUMC) Aerocrine AB Aerocrine AB (AEROCRINE)(AEROCRINE) University of Mancester University of Mancester (UMAN)(UMAN) Asthma UK Asthma UK (AUK)(AUK) ZorgGemak MedVision360 BV ZorgGemak MedVision360 BV (MV)(MV) Allertec Hellas Pharmaceutical Allertec Hellas Pharmaceutical (Allertec)(Allertec) Cnet Svenska ABCnet Svenska AB (CNET)(CNET)

ObjectivesObjectives

To raise public awareness of project developments among To raise public awareness of project developments among key user groups, the scientific community and the general key user groups, the scientific community and the general publicpublic

To facilitate sharing of knowledge inside the ConsortiumTo facilitate sharing of knowledge inside the Consortium

To develop a business plan for the project outcomesTo develop a business plan for the project outcomes

To manage Intellectual Property RightsTo manage Intellectual Property Rights

TasksTasks

T7.1T7.1 Dissemination activities, material and publication Dissemination activities, material and publication (Leader: EFA) D7.1; D7.2(Leader: EFA) D7.1; D7.2

T7.2 T7.2 Exploitation and myAirCoach Business models Exploitation and myAirCoach Business models (Leader: AEROCRINE) D7.3(Leader: AEROCRINE) D7.3

T7.3T7.3 IPR management IPR management (Leader: Allertec) D7.4(Leader: Allertec) D7.4

T7.4T7.4 Standardization and concertation actions Standardization and concertation actions (Leader: CERTH) D7.5(Leader: CERTH) D7.5

DeliverablesDeliverables

D7.1D7.1 Dissemination Plan and myAirCoach dissemination Dissemination Plan and myAirCoach dissemination material material (M3, M12, M24, M36, PU, Report)(M3, M12, M24, M36, PU, Report)

D7.2D7.2 Project Web Presence (Website, Wiki, Blog, Social Project Web Presence (Website, Wiki, Blog, Social Media) Media) (M3, PU, Report + Prototype)(M3, PU, Report + Prototype)

D7.3D7.3 Exploitation Report and myAirCoach Business models Exploitation Report and myAirCoach Business models (M24 preliminary, M36 final version, RE, Report)(M24 preliminary, M36 final version, RE, Report)

D7.4D7.4 IPR Protection Plan IPR Protection Plan (M12 preliminary, M24 final version, (M12 preliminary, M24 final version, RE, Report)RE, Report)

D7.5D7.5 Standardisation and concertation activities report Standardisation and concertation activities report (M24 (M24 preliminary, M36 final version, PU, Report)preliminary, M36 final version, PU, Report)

D7.6D7.6 Data Management Plan Data Management Plan (M6, updated at M24 and M36, PU, R+s/w)(M6, updated at M24 and M36, PU, R+s/w)

Milestones and indicatorsMilestones and indicators

MilestonesMilestones::M1:M1: Web site available Web site available M12:M12: Definition of exploitation scenarios. Signature of Definition of exploitation scenarios. Signature of Exploitation AgreementExploitation AgreementM13:M13: Business plan and market analysis available Business plan and market analysis available

Key success indicatorsKey success indicators::Dissemination materialDissemination material, including the web-site, are , including the web-site, are availableavailable. myAirCoach market analysis and business plan . myAirCoach market analysis and business plan highlights the major myAirCoach developments.highlights the major myAirCoach developments.Concertation activities Concertation activities with other projects and initiatives with with other projects and initiatives with similar objectives have similar objectives have resulted in benefit for all resulted in benefit for all involved involved parties and new joint initiativesparties and new joint initiatives

What to coWhat to communicatemmunicate

Objectives, strategic relevance and key factsObjectives, strategic relevance and key facts News regarding achievements and resultsNews regarding achievements and results Events promotion and events resultsEvents promotion and events results System’s findings that can help and support patientsSystem’s findings that can help and support patients

Project outputs to be disseminated:Project outputs to be disseminated: Ready for use solutions (Vitual community platform, patient Ready for use solutions (Vitual community platform, patient

guidance platform)guidance platform) Models, information, lessons learned and recommendations Models, information, lessons learned and recommendations

To whom to communicateTo whom to communicate

Clinicians Clinicians Practitioners in hospitalsPractitioners in hospitals Political institutionsPolitical institutions Members of EU CommissionMembers of EU Commission Nongovernmental organizationsNongovernmental organizations National and international scientistsNational and international scientists Participants of the myAirCoach test campaignsParticipants of the myAirCoach test campaigns Researchers and staff involved in myAirCoachResearchers and staff involved in myAirCoach Schools and other educational institutionsSchools and other educational institutions General publicGeneral public Industry, pharmaceutical companies, medical providers Industry, pharmaceutical companies, medical providers Mobile Mobile

Network operators, SMEs in the medical area, Health service Network operators, SMEs in the medical area, Health service providersproviders

ExploitationExploitation

Academic and research organizations:Academic and research organizations: Direct exploitationDirect exploitation by protecting the knowledge created and by by protecting the knowledge created and by

granting licenses for its usegranting licenses for its use Indirect exploitationIndirect exploitation by increasing the leadership in the respective by increasing the leadership in the respective

areas of researchareas of research

Industrial partners (SMEs): Industrial partners (SMEs): Direct exploitation Direct exploitation of technical developmentsof technical developments Indirect exploitation Indirect exploitation by leveraging potential business strengths by leveraging potential business strengths

through the association with other partnersthrough the association with other partners

End user authorities: End user authorities: through EFA and AUK membersthrough EFA and AUK members

Analysis, modelling and sensing of both physiological and environmental factors for the customized and predictive self-management of Asthma

H2020-PHC-2014-single-stageH2020-PHC-2014-single-stage

RIA - 643607RIA - 643607

Thank you for your attention!Thank you for your attention!

European Federation of Allergy and European Federation of Allergy and Airways Diseases Patients' Associations  Airways Diseases Patients' Associations 

(EFA)(EFA)

EFA 35 Rue du CongrèsEFA 35 Rue du Congrès

1000 Brussels, Belgium  1000 Brussels, Belgium 

wwww.efanet.orgww.efanet.org